Trial Profile
A Phase IIa Study Investigating MYK-224 in a Complementary Hypertrophic Cardiomyopathy (HCM) Population
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2018
Price :
$35
*
At a glance
- Drugs MYK 224 (Primary)
- Indications Hypertrophic cardiomyopathy
- Focus Therapeutic Use
- 08 Nov 2018 New trial record
- 30 Oct 2018 According to a MyoKardia media release, this trial is expected to initiate in 2020.